Evidence map›Paper›PMID 29142109›Full record

ArticleOpen biology2017

The Ndc80 complex targets Bod1 to human mitotic kinetochores.

Katharina Schleicher, Michael Porter, Sara Ten Have, Ramasubramanian Sundaramoorthy, Iain M Porter, Jason R Swedlow

Open access · goldAbstract read
In one paragraph

Article in Open biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Kinetochore assembly throughout the cell cycle.Seminars in cell & developmental biology · 2021
    Article
  6. Review
  7. Review
  8. Review
  9. Kinase and Phosphatase Cross-Talk at the Kinetochore.Frontiers in cell and developmental biology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Katharina SchleicherCentre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee, UK.ORCID 0000-0002-8819-7287
Michael PorterCentre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee, UK.ORCID 0000-0001-9573-5066
Sara Ten HaveCentre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee, UK.ORCID 0000-0002-0770-5842
Ramasubramanian SundaramoorthyCentre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee, UK.ORCID 0000-0003-4895-0980
Iain M PorterCentre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee, UK.ORCID 0000-0002-7520-7538
Jason R SwedlowCentre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee, UK j.r.swedlow@dundee.ac.uk.ORCID 0000-0002-2198-1958
Google (United States) · US

Funding

Medical Research Council MR/K015869/1Wellcome Trust 095931/Z/11/ZWellcome Trust 097945/B/11/Z
6 · The paper itself

Abstract

Regulation of protein phosphatase activity by endogenous protein inhibitors is an important mechanism to control protein phosphorylation in cells. We recently identified Biorientation defective 1 (Bod1) as a small protein inhibitor of protein phosphatase 2A containing the B56 regulatory subunit (PP2A-B56). This phosphatase controls the amount of phosphorylation of several kinetochore proteins and thus the establishment of load-bearing chromosome-spindle attachments in time for accurate separation of sister chromatids in mitosis. Like PP2A-B56, Bod1 directly localizes to mitotic kinetochores and is required for correct segregation of mitotic chromosomes. In this report, we have probed the spatio-temporal regulation of Bod1 during mitotic progression. Kinetochore localization of Bod1 increases from nuclear envelope breakdown until metaphase. Phosphorylation of Bod1 at threonine 95 (T95), which increases Bod1's binding to and inhibition of PP2A-B56, peaks in prometaphase when PP2A-B56 localization to kinetochores is highest. We demonstrate here that kinetochore targeting of Bod1 depends on the outer kinetochore protein Ndc80 and not PP2A-B56. Crucially, Bod1 depletion functionally affects Ndc80 phosphorylation at the N-terminal serine 55 (S55), as well as a number of other phosphorylation sites within the outer kinetochore, including Knl1 at serine 24 and 60 (S24, S60), and threonine T943 and T1155 (T943, T1155). Therefore, Ndc80 recruits a phosphatase inhibitor to kinetochores which directly feeds forward to regulate Ndc80, and Knl1 phosphorylation, including sites that mediate the attachment of microtubules to kinetochores.

Indexed as

MitosisCell Cycle ProteinsChromosome SegregationCytoskeletal ProteinsFeedback, PhysiologicalHeLa CellsHumansKinetochoresMicrotubule-Associated ProteinsNuclear EnvelopeNuclear ProteinsPhosphorylationProtein BindingProtein Processing, Post-TranslationalBod1 protein, humanCell Cycle ProteinsCytoskeletal ProteinsKnl1 protein, humanMicrotubule-Associated ProteinsNDC80 protein, humanNuclear ProteinsBOD1chromosome segregationkinetochoreKnl1Ndc80 complexPP2A inhibitor

Identifiers

PMID29142109
PMCPMC5717335
OpenAlexW2949453705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.